BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3476310)

  • 1. Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics.
    Seigneurin D; Champelovier P; Mouchiroud G; Berthier R; Leroux D; Prenant M; McGregor J; Starck J; Morle F; Micouin C
    Exp Hematol; 1987 Sep; 15(8):822-32. PubMed ID: 3476310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5).
    Adachi M; Ryo R; Sato T; Yamaguchi N
    Exp Hematol; 1991 Oct; 19(9):923-7. PubMed ID: 1893970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of four human monocytoid leukemia cell lines (JOSK-I, -S, -M and -K) with capabilities of monocyte-macrophage lineage differentiation and constitutive production of interleukin 1.
    Ohta M; Furukawa Y; Ide C; Akiyama N; Utakoji T; Miura Y; Saito M
    Cancer Res; 1986 Jun; 46(6):3067-74. PubMed ID: 3486043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in the cellular commitment of a human leukemic cell line: K 562.
    Vainchenker W; Testa U; Guichard J; Titeux M; Breton-Gorius J
    Blood Cells; 1981; 7(2):357-75. PubMed ID: 6945884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid and megakaryocytic properties of K-562 cell lines.
    Tabilio A; Pelicci PG; Vinci G; Mannoni P; Civin CI; Vainchenker W; Testa U; Lipinski M; Rochant H; Breton-Gorius J
    Cancer Res; 1983 Oct; 43(10):4569-74. PubMed ID: 6349795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
    Takahashi W; Sasaki K; Kvomatsu N; Mitani K
    Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.
    Rowley PT; Farley BA; LaBella S; Giuliano R; Leary JF
    Int J Cell Cloning; 1992 Jul; 10(4):232-40. PubMed ID: 1645031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
    Green AR; Rockman S; DeLuca E; Begley CG
    Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Philadelphia chromosome-positive cell line with multipotential properties.
    Nakayama T; Tohyama K; Imamura S; Yoshida A; Fukushima T; Tsutani H; Nakamura T; Wano Y; Ohno Y; Ueda T
    Anticancer Res; 1999; 19(1A):349-56. PubMed ID: 10226566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cell surface glycoproteins and antigens during differentiation of the human myeloid leukemia cell lines ML-1, ML-2, and HL-60.
    Stöckbauer P; Gahmberg CG; Andersson LC
    Cancer Res; 1985 Jun; 45(6):2821-6. PubMed ID: 3857122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-3 and ribavirin induce high level expression of megakaryocytic markers and messages during long-term treatment of a megakaryocytic leukemia cell line.
    Majumdar A; Kerby S; Stenberg PE; Mullikin B; Beckstead JH; Cooney DA; Seidman MM
    J Cell Physiol; 1994 Jul; 160(1):29-39. PubMed ID: 8021297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment in long term culture of megakaryocytic leukemia cells (EST-IU) from the marrow of a patient with leukemia and a mediastinal germ cell neoplasm.
    Sledge GW; Glant M; Jansen J; Heerema NA; Roth BJ; Goheen M; Hoffman R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2155-9. PubMed ID: 3004722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocytic development in liquid cultures of cryopreserved leukocyte stem cell concentrates from chronic myelogenous leukemia patients.
    Berthier R; Marin M; Duperray A; Prenant M; Newton I; Schweitzer A; Hollard D; Marguerie G
    Exp Hematol; 1987 Aug; 15(7):750-8. PubMed ID: 3301382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of megakaryocytic differentiation in a newly established human leukemic cell line by 12-o-tetradecanoylphorbol-13-acetate.
    Chiu CF; Lin CK; Liu SM; Tan TD; Chau WK; Lin FM
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):1-11. PubMed ID: 7553404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.